Back to Results
First PageMeta Content
Science / Pulmonary function testing / Clinical research / Scientific method / Spirometry / Placebo-controlled study / Medicine / Respiratory therapy / Respiratory physiology


GlaxoSmithKline Inc. 5 Moore Drive Research Triangle Park, NC[removed]ANORO™ ELLIPTA™ (Umeclidinium Bromide/Vilanterol Inhalation Powder) For Treatment of Chronic Obstructive Pulmonary Disease
Add to Reading List

Open Document

File Size: 2,15 MB

Share Result on Facebook

City

Research Triangle Park / /

Company

VI Treatment Group / GlaxoSmithKline Inc. / Table 10 Cardiovascular Special Interest Subgroup / TDI / Subgroups / AEs / Overall Subgroup / Table 9 Cardiovascular Special Interest Subgroup / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

Treatment of Chronic Obstructive Pulmonary Disease / /

MedicalCondition

Cardiac Disorders / Baseline COPD / /

Organization

FDA / Pulmonary-Allergy Drug Advisory Committee / /

Person

Adverse Cardiac / /

Product

Albuterol / Rescue Medication / Pulmonary-Allergy Drug / /

ProvinceOrState

North Carolina / /

PublishedMedium

Baseline / /

Technology

Pharmacokinetics / /

SocialTag